Emergency Department Co-testing for Human Immunodeficiency Virus When Testing for Gonorrhea and Chlamydia: A Readily Available, Missed Opportunity for Targeted HIV Testing in Emergency Departments
American Journal of Clinical Pathology · 2023
DOI: 10.1093/ajcp/aqac168 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Clinical Pathology, 2023. Verfasst von Michael P Phelan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Emergency Services Institute, Cleveland Clinic, Cleveland, OH, USA. Hauptthemen laut MEDLINE: Chlamydia, Chlamydia Infections, Gonorrhea, HIV Infections. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 9 Literaturangaben.
Abstract (Originalsprache)
Objectives
Conducting human immunodeficiency virus (HIV) testing in emergency departments (EDs) can be an effective approach to testing and reaching populations at highest risk of contracting HIV.
Methods
All gonorrhea and chlamydia (G/C) and HIV tests ordered in the Cleveland Clinic Health System’s 14 EDs were included in the analysis. Data were collected from electronic health records. Descriptive statistics, with medians and means, were computed.
Results
From January 1, 2019, to December 31, 2021, we reviewed ED visits for the purpose of sexually transmitted infection (STI) screening, with an emphasis on G/C screening. In October 2019, both HIV rapid testing and G/C testing began across all 14 Cleveland Clinic EDs. The overall rate of co-testing for HIV when obtaining a G/C test for STI evaluation increased overall to around 30% for our health system EDs, with some individual EDs approaching 60%.
Conclusions
The approach the Cleveland Clinic implemented is an effective way to test for HIV in the ED. Local health departments and stakeholders in HIV communities should support and collaborate with EDs in their jurisdictions to accelerate HIV testing initiatives by using an HIV plus G/C co-testing metric.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Emergency Services Institute, Cleveland Clinic, Cleveland, OH, USA.
- Department of Epidemiology, Surveillance, and Informatics, Cuyahoga County Board of Health, Cleveland, OH, USA.
- Immunopathology Laboratory, Robert J. Tomsich Pathology & Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH, USA.
- Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, OH, USA.
Zitieren
APA
Phelan, M. P., Panakkal, V., Muir, M., Seballos, S., & Kadkhoda, K. (2023). Emergency Department Co-testing for Human Immunodeficiency Virus When Testing for Gonorrhea and Chlamydia: A Readily Available, Missed Opportunity for Targeted HIV Testing in Emergency Departments. American Journal of Clinical Pathology. https://doi.org/10.1093/ajcp/aqac168
Vancouver
Phelan MP, Panakkal V, Muir M, Seballos S, Kadkhoda K. Emergency Department Co-testing for Human Immunodeficiency Virus When Testing for Gonorrhea and Chlamydia: A Readily Available, Missed Opportunity for Targeted HIV Testing in Emergency Departments. American Journal of Clinical Pathology. 2023. doi:10.1093/ajcp/aqac168
BibTeX
@article{Phelan2023,
author = {Phelan, Michael P and Panakkal, Vinothini and Muir, McKinsey and Seballos, Spencer and Kadkhoda, Kamran},
title = {Emergency Department Co-testing for Human Immunodeficiency Virus When Testing for Gonorrhea and Chlamydia: A Readily Available, Missed Opportunity for Targeted HIV Testing in Emergency Departments},
journal = {American Journal of Clinical Pathology},
year = {2023},
doi = {10.1093/ajcp/aqac168}
}
EUVIMED